Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Smith Nephew ADR Representing 2 Ord Shs SNN

Healthcare Medical Devices
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:SNN)

Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention  

GlobeNewswire April 18, 2024

Smith+Nephew's PICO(TM) Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

GlobeNewswire April 4, 2024

Smith+Nephew introduces the RENASYS(TM) EDGE Negative Pressure Wound Therapy System - an exciting new option in home-based care for patients living with chronic wounds

GlobeNewswire April 1, 2024

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

GlobeNewswire March 25, 2024

Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement

GlobeNewswire February 28, 2024

Smith+Nephew announces commercial launch of its AETOS(TM) Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

GlobeNewswire February 13, 2024

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting  

GlobeNewswire February 12, 2024

Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting

GlobeNewswire February 12, 2024

New study confirms Smith+Nephew's REGENETEN(TM) Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%

GlobeNewswire January 11, 2024
View More News ››

Opinion & Analysis (NYSE:SNN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:SNN)

New acquisition bodes well

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that it has entered into a definitive...
prested - December 28, 2023

RE:RE:Better earnings outlook

Patience is the word.  Stock has been a real dud after that spring rally. Granted much of the market is down,especially dividend...
willyk3 - October 11, 2023

Newly introduced.

Monday, April 24, 2023, 8:00 AM ET   Smith+Nephew introduces first of its kind handheld digital tensioning device for...
prested - April 24, 2023

RE:Better earnings outlook

It does bode well, but I always feel that management is a little stuffy and not as aggressive as it could be. Still, a safe investment...
prested - March 1, 2023

Better earnings outlook

The stock gets a nice pop. Hope it bodes well for the next few years
willyk3 - February 21, 2023

RE:Currency not company the problem here

Couldn't agree more. Time will tell
willyk3 - January 31, 2023
View more Bullboard ››

Pulsar Helium Inc.

Pulsar Helium Inc.

Pulsar Helium Inc. is a Canada-based helium exploration and development company. The Company's assets include the flagship ...
View More »